Eotaxin was described to be increased in obese patients with metabolic syndrome (mean BMI 38.9 ± 6.3) compared to lean subjects (mean BMI 22.4 ± 2.5) and decreased after their weight-loss [45]. The gene discussed is CCL11; the disease is metabolic syndrome.